@BentheFidler Ben Fidler

Ben Fidler posts on X about $lly, $pfe, $bmy, $nvo the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

• [--] Week [-----] -23%
• [--] Month [------] +29%
• [--] Months [-------] +37%
• [--] Year [-------] -17%

Mentions: [--] #

• [--] Month [--] -49%
• [--] Months [---] +7.90%
• [--] Year [---] -14%

Followers: [-----] #

• [--] Week [-----] -0.02%
• [--] Month [-----] +0.24%
• [--] Months [-----] +1.40%
• [--] Year [-----] +2.80%

CreatorRank: [---------] #

Social Influence

Social category influence stocks 84.14% finance 8.97% cryptocurrencies 8.97% currencies 6.21% countries 2.76% technology brands 2.07% vc firms 1.38% us election 0.69%

Social topic influence $lly #141, $pfe 13.79%, $bmy #43, $nvo #312, $mrk #131, $bmrn #16, $jnj #85, $azn #107, $amgn #98, $nvs 5.52%

Top accounts mentioned or mentioned by @byjongardner @gwendolynawu @lilahalvarado @realjacobbell @alexlash @biopharmadive @nedpagliarulo @scottgottliebmd @postopinions @iambicai @rebeccampifer @neavc @alnylam @atlasventure @luxcapital @editasmed @archimedes20311

Top assets mentioned Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) Bristol-Myers Squibb Co (BMY) Novo-Nordisk (NVO) Merck & Co., Inc. (MRK) BioMarin Pharmaceutical, Inc. (BMRN) Johnson & Johnson (JNJ) AstraZeneca PLC (AZN) Amgen, Inc. (AMGN) Novartis AG (NVS) Synthetify (SNY) AbbVie Inc (ABBV) GSK plc (GSK) Regeneron Pharmaceuticals Inc (REGN) Gilead Sciences, Inc. (GILD) Sanofi (SNY) BridgeBio Pharma, Inc. Common Stock (BBIO) Insmed, Inc. (INSM) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Hims & Hers Health, Inc. (HIMS) Moderna Inc (MRNA) Intellia Therapeutics, Inc (NTLA) Alnylam Pharmaceuticals, Inc. (ALNY) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Vertex Protocol (VRTX) Arvinas, Inc (ARVN) Incyte Corporation (INCY) Agios Pharmaceuticals, Inc. (AGIO) Roivant Sciences Ltd. Common Shares (ROIV) Evommune, Inc. (EVMN) Metsera, Inc. (MTSR) Biogen Inc (BIIB) Amicus Therapeutics, Inc (FOLD) Sage Therapeutics, Inc (SAGE) PTC Therapeutics, Inc. (PTCT) Arcellx, Inc. (ACLX) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Lexeo Therapeutics, Inc (LXEO) Janux Therapeutics, Inc. (JANX) Terns Pharmaceuticals, Inc. (TERN) Corcept Therapeutics Inc. (CORT) Sarepta Therapeutics, Inc. (SRPT) Arrowhead Research Corporation (ARWR) Instil Bio, Inc. (TIL) Summit Therapeutics Inc. Common Stock (SMMT) Upstream Bio, Inc. (UPB) Cytokinetics Inc. (CYTK) Halozyme Therapeutics, Inc. (HALO) Wave Life Sciences Ltd. Ordinary Shares (WVE) BEAM (BEAM)

Top Social Posts

Top posts by engagements in the last [--] hours

"Lilly bets again on China drugs; Roche showcases MS data $LLY $RHHBY $ROIV $GILD https://www.biopharmadive.com/news/lilly-bets-again-on-china-drugs-roche-showcases-ms-data/811669/ https://www.biopharmadive.com/news/lilly-bets-again-on-china-drugs-roche-showcases-ms-data/811669/"
X Link 2026-02-09T17:12Z [----] followers, [---] engagements

"Evommune nabs $150M in #IPO amid federal shutdown by @gwendolynawu $EVMN https://www.biopharmadive.com/news/evommune-ipo-pricing-chronic-spontaneous-urticaria-hives/804677/ https://www.biopharmadive.com/news/evommune-ipo-pricing-chronic-spontaneous-urticaria-hives/804677/"
X Link 2025-11-06T01:53Z [----] followers, [---] engagements

"J&Js remarkable Tecvayli data support earlier use in multiple myeloma @ByJonGardner $JNJ #ASH25 $ACLX $BMY https://www.biopharmadive.com/news/johnson-johnson-tecvayli-darzalex-ash-multiple-myeloma-results/807234/ https://www.biopharmadive.com/news/johnson-johnson-tecvayli-darzalex-ash-multiple-myeloma-results/807234/"
X Link 2025-12-09T12:37Z [----] followers, [---] engagements

"Insmeds ginormous lung drug sales; J&Js US pricing deal $INSM $MLTX $LLY $LXEO $JNJ https://www.biopharmadive.com/news/johnson-price-insmed-moonlake-madrigal-pfizer-lexeo-lilly/809169/ https://www.biopharmadive.com/news/johnson-price-insmed-moonlake-madrigal-pfizer-lexeo-lilly/809169/"
X Link 2026-01-09T16:39Z [----] followers, [---] engagements

"BioMarin vets form Mendra to modernize rare disease drug development by Kristin Jensen #biotech #startups $BMRN https://www.biopharmadive.com/news/mendra-rare-disease-biotech-startup-ai-biomarin-financing/810204/ https://www.biopharmadive.com/news/mendra-rare-disease-biotech-startup-ai-biomarin-financing/810204/"
X Link 2026-01-22T17:03Z [----] followers, [---] engagements

"Bristol Myers buys into Januxs masked T cell engagers by @Lilah_Alvarado $JANX $BMY $MRK https://www.biopharmadive.com/news/janux-bristol-myers-partnership-t-cell-engagers-cancer/810227/ https://www.biopharmadive.com/news/janux-bristol-myers-partnership-t-cell-engagers-cancer/810227/"
X Link 2026-01-22T17:42Z [----] followers, [----] engagements

"Novo climbs higher on strong Wegovy pill launch; Terns tweaks leukemia drug deal $NVO + 2% $TERN $CORT https://www.biopharmadive.com/news/wegovy-pill-prescriptions-terns-deal-corcept-data-biomerieux/810253/ https://www.biopharmadive.com/news/wegovy-pill-prescriptions-terns-deal-corcept-data-biomerieux/810253/"
X Link 2026-01-23T16:01Z [----] followers, [---] engagements

"Sarepta battling slowing sales claims Duchenne gene therapys impact grows with time @ByJonGardner $SRPT + 12% https://www.biopharmadive.com/news/sarepta-elevidys-duchenne-gene-therapy-embark-data/810461/ https://www.biopharmadive.com/news/sarepta-elevidys-duchenne-gene-therapy-embark-data/810461/"
X Link 2026-01-26T17:04Z [----] followers, [---] engagements

"Regenxbio gene therapy trials suspended by FDA over safety worries by Kristin Jensen $RGNX - 17% #GeneTherapy https://www.biopharmadive.com/news/regenxbio-fda-hold-hunter-hurler-syndrome-gene-therapy/810691/ https://www.biopharmadive.com/news/regenxbio-fda-hold-hunter-hurler-syndrome-gene-therapy/810691/"
X Link 2026-01-28T16:23Z [----] followers, [----] engagements

"Drugs for cancer arthritis and HIV on Medicares list for [----] price cuts $LLY $GILD $PFE $NVS https://www.biopharmadive.com/news/medicare-drug-price-2028-trulicity-biktarvy-verzenio-kisqali/810688/ https://www.biopharmadive.com/news/medicare-drug-price-2028-trulicity-biktarvy-verzenio-kisqali/810688/"
X Link 2026-01-28T16:58Z [----] followers, [---] engagements

"Sanofi expects vaccine sales growth to dip amid challenging environment by @Lilah_Alvarado $SNY https://www.biopharmadive.com/news/sanofi-vaccine-sales-fourth-quarter-2025-earnings/810829/ https://www.biopharmadive.com/news/sanofi-vaccine-sales-fourth-quarter-2025-earnings/810829/"
X Link 2026-01-29T17:12Z [----] followers, [---] engagements

"Right after pledging $15B to China $AZN is picking up several #obesity assets via a potentially $18B+ alliance with CSPC https://doc.irasia.com/listco/hk/cspc/announcement/a260130.pdf https://doc.irasia.com/listco/hk/cspc/announcement/a260130.pdf"
X Link 2026-01-30T02:29Z [----] followers, [----] engagements

"Amgen gives up on its once-prized eczema drug @ByJonGardner $AMGN $SNY https://www.biopharmadive.com/news/amgen-return-rocatinlimab-kyowa-kirin-atopic-dermatitis-eczma-ox40/810964/ https://www.biopharmadive.com/news/amgen-return-rocatinlimab-kyowa-kirin-atopic-dermatitis-eczma-ox40/810964/"
X Link 2026-01-30T17:13Z [----] followers, [---] engagements

"Sanofi drug inherited from Genzyme goes 1-for-2 in rare disease trials by @Lilah_Alvarado $SNY https://www.biopharmadive.com/news/sanofi-venglustat-gaucher-fabry-study-results/811113/ https://www.biopharmadive.com/news/sanofi-venglustat-gaucher-fabry-study-results/811113/"
X Link 2026-02-02T17:26Z [----] followers, [---] engagements

"Pfizer dips on new data for #obesity drug acquired in $10B deal @ByJonGardner $PFE - 3% $MTSR $LLY $NVO https://www.biopharmadive.com/news/pfizer-obesity-metsera-phase-2-results-GLP1-monthly-shot/811201/ https://www.biopharmadive.com/news/pfizer-obesity-metsera-phase-2-results-GLP1-monthly-shot/811201/"
X Link 2026-02-03T17:10Z [----] followers, [---] engagements

"Lilly soars again as fast-selling weight loss drugs top Wall Street projections by Kristin Jensen $LLY + 10% #obesity https://www.biopharmadive.com/news/lilly-earnings-guidance-q4-2025-obesity-drugs/811317/ https://www.biopharmadive.com/news/lilly-earnings-guidance-q4-2025-obesity-drugs/811317/"
X Link 2026-02-04T16:23Z [----] followers, [---] engagements

"New: Eikon Therapeutics nets a $381M #IPO amid burst of #biotech offerings by @gwendolynawu $EIKN $MANE $AGMB $SGP https://www.biopharmadive.com/news/eikon-biotech-ipo-price-cancer-drugs-2026/811169/ https://www.biopharmadive.com/news/eikon-biotech-ipo-price-cancer-drugs-2026/811169/"
X Link 2026-02-05T01:18Z [----] followers, [----] engagements

"Novo Lilly sputter as Hims launches knockoff GLP-1 pill $HIMS $LLY - 7% $NVO - 6% #obesity https://www.biopharmadive.com/news/hims-compounded-wegovy-glp-1-obesity-novo-lilly/811476/ https://www.biopharmadive.com/news/hims-compounded-wegovy-glp-1-obesity-novo-lilly/811476/"
X Link 2026-02-05T17:45Z [----] followers, [---] engagements

"Earnings roundup: AbbVie angst a bifurcated vaccine market and Bristol Myers waiting game by @realJacobBell and @Lilah_Alvarado #biotech $ABBV $BMY $GSK https://www.biopharmadive.com/news/bristol-myers-abbvie-gsk-vaccines-biotech-earnings-q4-2025/811463/ https://www.biopharmadive.com/news/bristol-myers-abbvie-gsk-vaccines-biotech-earnings-q4-2025/811463/"
X Link 2026-02-05T21:54Z [----] followers, [---] engagements

"RT @ScottGottliebMD: My Op Ed in Today's @PostOpinions "The long-lasting effects of viruses and the anti-vaccine movement. For some peopl"
X Link 2026-02-06T15:09Z [----] followers, [--] engagements

"White Houses online service for drug sales debuts with limited impact on prices @ByJonGardner https://www.biopharmadive.com/news/trump-rx-drug-prices-discount-white-house/811576/ https://www.biopharmadive.com/news/trump-rx-drug-prices-discount-white-house/811576/"
X Link 2026-02-06T17:18Z [----] followers, [---] engagements

"Hims cancels plans to sell compounded GLP-1 pill after FDA backlash $HIMS $NVO #obesity https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/ https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/"
X Link 2026-02-08T01:15Z [----] followers, [---] engagements

"Updated w/ news of Novo's lawsuit: Hims cancels plans to sell compounded GLP-1 pill after FDA backlash $HIMS $NVO #obesity https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/ https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/"
X Link 2026-02-09T13:06Z [----] followers, [---] engagements

"Takeda Iambic partner in latest pharma AI push by @realJacobBell $TAK @iambic_ai #biotech https://www.biopharmadive.com/news/takeda-iambic-ai-drug-discovery-deal-biotech/811643/ https://www.biopharmadive.com/news/takeda-iambic-ai-drug-discovery-deal-biotech/811643/"
X Link 2026-02-09T13:09Z [----] followers, [---] engagements

"Lilly buys in vivo CAR-T maker Orna extending streak of genetic medicine deals @ByJonGardner $LLY $BMY $GILD $AZN $ABBV https://www.biopharmadive.com/news/lilly-orna-acquire-in-vivo-cell-therapy-autoimmune/811692/ https://www.biopharmadive.com/news/lilly-orna-acquire-in-vivo-cell-therapy-autoimmune/811692/"
X Link 2026-02-09T17:19Z [----] followers, [---] engagements

"Hengrui Kailera tout positive results for dual-acting obesity pill by @Lilah_Alvarado #obesity $LLY $NVO https://www.biopharmadive.com/news/kailera-hengrui-oral-ribupatide-study-results-china/811718/ https://www.biopharmadive.com/news/kailera-hengrui-oral-ribupatide-study-results-china/811718/"
X Link 2026-02-10T13:18Z [----] followers, [---] engagements

"FDA rejects Regenxbio treatment in another blow to gene therapy by @gwendolynawu $RGNX - 14% #GeneTherapy https://www.biopharmadive.com/news/regenxbio-fda-reject-gene-therapy-mps-hunter-syndrome/811775/ https://www.biopharmadive.com/news/regenxbio-fda-reject-gene-therapy-mps-hunter-syndrome/811775/"
X Link 2026-02-10T17:04Z [----] followers, [---] engagements

"Nektar continuing comeback says eczema drugs effects hold up in follow-up study @ByJonGardner $NKTR + 43% $REGN $CRVS $SNY https://www.biopharmadive.com/news/nektar-rezpegaldesleukin-eczema-maintenance-data-results/811806/ https://www.biopharmadive.com/news/nektar-rezpegaldesleukin-eczema-maintenance-data-results/811806/"
X Link 2026-02-10T17:15Z [----] followers, [---] engagements

"Gilead dips as strong earnings outweighed by high expectations for new HIV drug by @realJacobBell $GILD - 2% https://www.biopharmadive.com/news/gilead-yeztugo-earnings-q4-full-year-hiv-sales/811908/ https://www.biopharmadive.com/news/gilead-yeztugo-earnings-q4-full-year-hiv-sales/811908/"
X Link 2026-02-11T12:54Z [----] followers, [---] engagements

"FDA refuses to review Modernas mRNA flu vaccine by @Lilah_Alvarado $MRNA - 10% https://www.biopharmadive.com/news/moderna-fda-influenza-mrna-refuse-to-file/811909/ https://www.biopharmadive.com/news/moderna-fda-influenza-mrna-refuse-to-file/811909/"
X Link 2026-02-11T13:40Z [----] followers, [---] engagements

"BridgeBio scores with dwarfism drug setting up showdown with BioMarin Ascendis by @realJacobBell $BBIO $ASND $BMRN https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/ https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/"
X Link 2026-02-12T12:43Z [----] followers, [---] engagements

"Seres to lay off staff pause top program in latest reboot by @Lilah_Alvarado $MCRB - 37% https://www.biopharmadive.com/news/seres-layoffs-restructuring-microbiome-immune-disease/812079/ https://www.biopharmadive.com/news/seres-layoffs-restructuring-microbiome-immune-disease/812079/"
X Link 2026-02-12T17:06Z [----] followers, [---] engagements

"Arrowhead showcases early obesity data; Instil bails on PD-1/VEGF drug $ARWR $TIL $JNJ $LLY $AMGN https://www.biopharmadive.com/news/arrowhead-obesity-instil-amgen-nimbus-disco-nipocalimab-lupus/808873/ https://www.biopharmadive.com/news/arrowhead-obesity-instil-amgen-nimbus-disco-nipocalimab-lupus/808873/"
X Link 2026-01-07T15:50Z [----] followers, [---] engagements

"FDA lifts hold on an Intellia CRISPR drug trial by @Lilah_Alvarado $NTLA + 10% $ALNY $BBIO $PFE https://www.biopharmadive.com/news/intellia-fda-lifts-hold-nex-z-crispr-ttr-amyloidosis/810584/ https://www.biopharmadive.com/news/intellia-fda-lifts-hold-nex-z-crispr-ttr-amyloidosis/810584/"
X Link 2026-01-27T17:07Z [----] followers, [---] engagements

"Moderna holds a garage sale; Roche defends #obesity drug data $MRNA $RHHBY $LLY $SMMT #biotech https://www.biopharmadive.com/news/moderna-recordati-roche-obesity-summit-lilly-repertoire/810853/ https://www.biopharmadive.com/news/moderna-recordati-roche-obesity-summit-lilly-repertoire/810853/"
X Link 2026-01-30T15:54Z [----] followers, [---] engagements

"New: Earnings roundup: Amgen vs. FDA Pfizers defense and Mercks $70B-in-sales plan $AMGN $PFE $MRK #biotech https://www.biopharmadive.com/news/amgen-pfizer-merck-fda-biotech-earnings-q4-2025/811287/ https://www.biopharmadive.com/news/amgen-pfizer-merck-fda-biotech-earnings-q4-2025/811287/"
X Link 2026-02-04T14:54Z [----] followers, [---] engagements

"Madrigal turns to RNAi drugs from China to bolster MASH pipeline by Kristin Jensen $MDGL https://www.biopharmadive.com/news/madrigal-suzhou-ribo-mash-rnai-drug-deal-china/811920/ https://www.biopharmadive.com/news/madrigal-suzhou-ribo-mash-rnai-drug-deal-china/811920/"
X Link 2026-02-11T16:06Z [----] followers, [---] engagements

"Updated w/ more details: BridgeBio scores with dwarfism drug setting up showdown with BioMarin Ascendis by @realJacobBell $BBIO + 15% $BMRN - 5% $ASND - 4% https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/ https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/"
X Link 2026-02-12T14:08Z [----] followers, [---] engagements

"Agomab SpyGlass bank a combined $350M in biotech IPOs by @gwendolynawu $AGMB $SGP $MANE $EIKN #IPO https://www.biopharmadive.com/news/agomab-spyglass-biotech-ipo-price-2026/811385/ https://www.biopharmadive.com/news/agomab-spyglass-biotech-ipo-price-2026/811385/"
X Link 2026-02-06T01:31Z [----] followers, [---] engagements

"Bayer details anticipated stroke prevention data for new blood-thinner @ByJonGardner $BAYRY $BMY $JNJ $REGN https://www.biopharmadive.com/news/bayer-asundexian-factorXIa-secondary-stroke-data-conference/811455/ https://www.biopharmadive.com/news/bayer-asundexian-factorXIa-secondary-stroke-data-conference/811455/"
X Link 2026-02-05T17:18Z [----] followers, [---] engagements

"Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill $EVMN $AZN $UPB - 51% $MRNA $TAK #biotech https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/ https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/"
X Link 2026-02-11T16:01Z [----] followers, [---] engagements

"Halozyme buys a #biotech startup; Cytokinetics launches heart drug $HALO $GSK $CYTK https://www.biopharmadive.com/news/halozyme-surf-myqorzo-boehringer-china-gsk-rsv-epidarex/810539/ https://www.biopharmadive.com/news/halozyme-surf-myqorzo-boehringer-china-gsk-rsv-epidarex/810539/"
X Link 2026-01-28T16:46Z [----] followers, [---] engagements

"GSK walks away from pioneering Wave RNA editing drug $WVE $KRRO $GSK $BEAM https://www.biopharmadive.com/news/wave-gsk-reacquire-rna-editing-drug-aatd/811067/ https://www.biopharmadive.com/news/wave-gsk-reacquire-rna-editing-drug-aatd/811067/"
X Link 2026-02-02T14:15Z [----] followers, [----] engagements

"Sanofi looking for more rigor swaps CEO Hudson for ex-Merck KGaA chief Garijo by Kristin Jensen $SNY - 4% $MKKGY https://www.biopharmadive.com/news/sanofi-ceo-paul-hudson-belen-garijo/812061/ https://www.biopharmadive.com/news/sanofi-ceo-paul-hudson-belen-garijo/812061/"
X Link 2026-02-12T16:12Z [----] followers, [---] engagements

"Earnings roundup: Neurocrine slumps Alnylam battles skeptics and Ascendis eyes a competitor by @realJacobBell $NBIX - 10% $ALNY - 4% $ASND - 2% $BBIO #biotech https://www.biopharmadive.com/news/alnylam-neurocrine-ascendis-biotech-earnings-4q-2025/812137/ https://www.biopharmadive.com/news/alnylam-neurocrine-ascendis-biotech-earnings-4q-2025/812137/"
X Link 2026-02-12T22:27Z [----] followers, [---] engagements

"In rumored AbbVie deal Wall Street sees momentum for psychedelics M&A $ABBV $ATAI + 18% $GHRS $CMPS + 10% $MNMD https://www.biopharmadive.com/news/psychedelics-dealmaking-wall-street-abbvie-gilgamesh/756496/ https://www.biopharmadive.com/news/psychedelics-dealmaking-wall-street-abbvie-gilgamesh/756496/"
X Link 2025-07-31T21:03Z [----] followers, [---] engagements

"Regeneron cancer bispecific rejected again; Allogene discloses trial death $ALLO $REGN $ARGX $BIIB $BMY https://www.biopharmadive.com/news/regeneron-odronextamab-crl-allogene-patient-death-bristol-myers-earnings/756464/ https://www.biopharmadive.com/news/regeneron-odronextamab-crl-allogene-patient-death-bristol-myers-earnings/756464/"
X Link 2025-08-01T15:14Z [----] followers, [---] engagements

"Vertex plan to build on pain drug breakthrough hits hurdles by @NedPagliarulo $VRTX - 14% https://www.biopharmadive.com/news/vertex-pain-neuropathic-delay-vx-993-negative-trial/756753/ https://www.biopharmadive.com/news/vertex-pain-neuropathic-delay-vx-993-negative-trial/756753/"
X Link 2025-08-05T10:33Z [----] followers, [---] engagements

"New: US #biotech needs government support to match Chinas gains Pfizer CEO says $PFE https://www.biopharmadive.com/news/china-biotech-drug-deals-pfizer-bourla-comments/756880/ https://www.biopharmadive.com/news/china-biotech-drug-deals-pfizer-bourla-comments/756880/"
X Link 2025-08-06T01:07Z [----] followers, [---] engagements

"Nxera debuts an obesity pipeline; BridgeBio battles Alynam for market share $BBIO - 11% $ALNY $MDGL $MCRB $BMRN https://www.biopharmadive.com/news/nxera-glp-1-bridgebio-attruby-madrigal-rezdiffra-sales/756914/ https://www.biopharmadive.com/news/nxera-glp-1-bridgebio-attruby-madrigal-rezdiffra-sales/756914/"
X Link 2025-08-06T15:49Z [----] followers, [---] engagements

"Novo pushes back against obesity drug compounders as competition intensifies @ByJonGardner $NVO $LLY https://www.biopharmadive.com/news/novo-nordisk-wegovy-obesity-compounders-second-quarter-2025-earnings/756916/ https://www.biopharmadive.com/news/novo-nordisk-wegovy-obesity-compounders-second-quarter-2025-earnings/756916/"
X Link 2025-08-06T16:43Z [----] followers, [---] engagements

"Iovance cuts staff amid slow sales start for TIL cell therapy $IOVA https://www.biopharmadive.com/news/iovance-layoffs-restructuring-amtagvi-sales-guidance/757041/ https://www.biopharmadive.com/news/iovance-layoffs-restructuring-amtagvi-sales-guidance/757041/"
X Link 2025-08-07T14:03Z [----] followers, [---] engagements

"Arvinas Pfizer reworking partnership on Protac cancer drug by Kristin Jensen $ARVN $PFE https://www.biopharmadive.com/news/arvinas-pfizer-vepdegestrant-partnership-rework-breast-cancer/757043/ https://www.biopharmadive.com/news/arvinas-pfizer-vepdegestrant-partnership-rework-breast-cancer/757043/"
X Link 2025-08-07T15:33Z [----] followers, [--] engagements

"Strand raises another $153M to make programmable mRNA drugs by @gwendolynawu #biotech #startups https://www.biopharmadive.com/news/strand-series-b-mrna-cancer-jake-becraft/757101/ https://www.biopharmadive.com/news/strand-series-b-mrna-cancer-jake-becraft/757101/"
X Link 2025-08-07T20:39Z [----] followers, [---] engagements

"Expedition a startup searching for drugs from China cuts its first deal $AZN $INSM #biotech #startups https://www.biopharmadive.com/news/expedition-fosun-china-licensing-deal-dpp1-biotech-startup/757394/ https://www.biopharmadive.com/news/expedition-fosun-china-licensing-deal-dpp1-biotech-startup/757394/"
X Link 2025-08-12T13:42Z [----] followers, [---] engagements

"Pfizer looks to expand ADC use after positive bladder cancer data @ByJonGardner $PFE $MRK https://www.biopharmadive.com/news/padcev-keytruda-neoadjuvant-adjuvant-bladder-cancer-positive-data-pfizer-merck/757441/ https://www.biopharmadive.com/news/padcev-keytruda-neoadjuvant-adjuvant-bladder-cancer-positive-data-pfizer-merck/757441/"
X Link 2025-08-12T16:18Z [----] followers, [---] engagements

"Vor says drug licensed from RemeGen succeeded in Sjgrens study by @NedPagliarulo $VOR + 18% $NVS $VRTX $VERA https://www.biopharmadive.com/news/remegen-vor-telitacicept-sjorgens-phase-3-study/757532/ https://www.biopharmadive.com/news/remegen-vor-telitacicept-sjorgens-phase-3-study/757532/"
X Link 2025-08-13T15:15Z [----] followers, [---] engagements

"Vedanta PureTechs microbiome #startup to cut staff after study setback $MCRB $JNJ $PRTC https://www.biopharmadive.com/news/vedanta-layoffs-ulcerative-colitis-study-results-microbiome-puretech/757650/ https://www.biopharmadive.com/news/vedanta-layoffs-ulcerative-colitis-study-results-microbiome-puretech/757650/"
X Link 2025-08-14T13:36Z [----] followers, [---] engagements

"Lilly says it will raise drug prices in Europe responding to Trump threats @ByJonGardner $LLY https://www.biopharmadive.com/news/lilly-drug-prices-europe-most-favored-nation-uk-mounjaro/757704/ https://www.biopharmadive.com/news/lilly-drug-prices-europe-most-favored-nation-uk-mounjaro/757704/"
X Link 2025-08-14T19:31Z [----] followers, [---] engagements

"Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial $PGEN $PFE $LLY $AUTL $GBIO https://www.biopharmadive.com/news/precigen-approval-prasad-pfizer-inclacumab-sickle-cell-lilly-superluminal/757738/ https://www.biopharmadive.com/news/precigen-approval-prasad-pfizer-inclacumab-sickle-cell-lilly-superluminal/757738/"
X Link 2025-08-15T15:37Z [----] followers, [---] engagements

"Novos Wegovy becomes first GLP-1 drug approved for MASH $NVO + 4% $MDGL - 5% https://www.biopharmadive.com/news/novo-wegovy-mash-fda-approval-rezdiffra-madrigal/757853/ https://www.biopharmadive.com/news/novo-wegovy-mash-fda-approval-rezdiffra-madrigal/757853/"
X Link 2025-08-18T13:13Z [----] followers, [---] engagements

"Breaking: FDA approves Ionis hereditary angioedema drug by @gwendolynawu $IONS $BCRX $NTLA https://www.biopharmadive.com/news/ionis-donidalorsen-dawnzera-hereditary-angioedema-approval-fda/758195/ https://www.biopharmadive.com/news/ionis-donidalorsen-dawnzera-hereditary-angioedema-approval-fda/758195/"
X Link 2025-08-21T16:06Z [----] followers, [----] engagements

"Gilead dives into in vivo cell therapy with $350M buyout of Interius @ByJonGardner $GILD $ABBV $AZN https://www.biopharmadive.com/news/gilead-interius-acquire-in-vivo-cell-therapy/758266/ https://www.biopharmadive.com/news/gilead-interius-acquire-in-vivo-cell-therapy/758266/"
X Link 2025-08-21T16:10Z [----] followers, [---] engagements

"Over [----] HHS employees call on RFK Jr. to step down by @RebeccaMPifer https://www.biopharmadive.com/news/hhs-staff-letter-rfk-jr-kennedy-resign-cdc-monarez/759133/ https://www.biopharmadive.com/news/hhs-staff-letter-rfk-jr-kennedy-resign-cdc-monarez/759133/"
X Link 2025-09-03T16:03Z [----] followers, [---] engagements

"Sanofis touted eczema drug hits study goal but data fall short of expectations by Kristin Jensen $SNY - 8% $AMGN https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-atopic-dermatitis-study-results-disappoint-analysts/759231/ https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-atopic-dermatitis-study-results-disappoint-analysts/759231/"
X Link 2025-09-04T15:17Z [----] followers, [---] engagements

"At Senate hearing lawmakers express dissatisfaction with RFK Jr.s vaccine moves by @Lilah_Alvarado and @ByJonGardner https://www.biopharmadive.com/news/kennedy-rfk-senate-hearing-vaccines-cdc-crisis-acip/759319/ https://www.biopharmadive.com/news/kennedy-rfk-senate-hearing-vaccines-cdc-crisis-acip/759319/"
X Link 2025-09-04T20:20Z [----] followers, [---] engagements

"A UK #biotech takes aim at Parkinsons ALS by drugging mitochondria by @gwendolynawu #startups https://www.biopharmadive.com/news/nrg-therapeutics-series-b-parkinsons-als-mitochondria-mptp/759403/ https://www.biopharmadive.com/news/nrg-therapeutics-series-b-parkinsons-als-mitochondria-mptp/759403/"
X Link 2025-09-08T16:06Z [----] followers, [---] engagements

"Novo Nordisk to lay off [----] workers in major restructuring by Kristin Jensen $NVO $LLY https://www.biopharmadive.com/news/novo-nordisk-layoffs-restructuring-obesity-drug-competition/759748/ https://www.biopharmadive.com/news/novo-nordisk-layoffs-restructuring-obesity-drug-competition/759748/"
X Link 2025-09-10T15:06Z [----] followers, [----] engagements

"Kriya Odyssey secure megarounds; Amgen boosts R&D leadership #startups #IPO $AMGN $DNTH $MRK https://www.biopharmadive.com/news/kriya-odyssey-megarounds-amgen-research-leadership-dianthus-gmg/759723/ https://www.biopharmadive.com/news/kriya-odyssey-megarounds-amgen-research-leadership-dianthus-gmg/759723/"
X Link 2025-09-10T15:59Z [----] followers, [---] engagements

"FDA clears J&Js drug-device combo for bladder cancer @ByJonGardner $JNJ $CGON https://www.biopharmadive.com/news/fda-inlexzo-approval-johnson-johnson-bladder-cancer/759727/ https://www.biopharmadive.com/news/fda-inlexzo-approval-johnson-johnson-bladder-cancer/759727/"
X Link 2025-09-10T16:03Z [----] followers, [----] engagements

"Novartis dives deeper into protein degraders with second Monte Rosa deal $NVS $GLUE + 42% https://www.biopharmadive.com/news/novartis-monte-rosa-molecular-glue-degrader-partnership-immune-drugs/760084/ https://www.biopharmadive.com/news/novartis-monte-rosa-molecular-glue-degrader-partnership-immune-drugs/760084/"
X Link 2025-09-15T13:46Z [----] followers, [---] engagements

"Former CinCor execs reunite to helm new #biotech #startup by @gwendolynawu $SNY https://www.biopharmadive.com/news/allrock-bio-cincor-sanofi-rock-inhibitor/760043/ https://www.biopharmadive.com/news/allrock-bio-cincor-sanofi-rock-inhibitor/760043/"
X Link 2025-09-16T12:38Z [----] followers, [---] engagements

"Ollin debuts with $100M and plans to challenge top-selling eye drugs by @gwendolynawu #biotech #startups $AMGN $RHHBY $REGN https://www.biopharmadive.com/news/ollin-biosciences-ophthalmology-startup-vabysmo-tepezza/760182/ https://www.biopharmadive.com/news/ollin-biosciences-ophthalmology-startup-vabysmo-tepezza/760182/"
X Link 2025-09-17T10:33Z [----] followers, [---] engagements

"GSK ups US investment with $30B spending plan by @NedPagliarulo $GSK https://www.biopharmadive.com/news/gsk-us-manufacturing-investment-30-billion-pennsylvania/760366/ https://www.biopharmadive.com/news/gsk-us-manufacturing-investment-30-billion-pennsylvania/760366/"
X Link 2025-09-17T15:49Z [----] followers, [---] engagements

"Roivant pill succeeds in rare inflammatory disease trial @ByJonGardner $ROIV + 10% https://www.biopharmadive.com/news/roivant-pfizer-brepocitinib-trial-dermatomyositis/760368/ https://www.biopharmadive.com/news/roivant-pfizer-brepocitinib-trial-dermatomyositis/760368/"
X Link 2025-09-17T15:52Z [----] followers, [---] engagements

"Roche dives into MASH with $2.4B deal for 89bio $ETNB $AKRO $GSK $NVO $RHHBY https://www.biopharmadive.com/news/roche-89bio-deal-acquire-mash-drug-fgf21-pegozafermin/760483/ https://www.biopharmadive.com/news/roche-89bio-deal-acquire-mash-drug-fgf21-pegozafermin/760483/"
X Link 2025-09-18T14:33Z [----] followers, [---] engagements

"Biogen to buy startup Alcyone eyeing easier delivery of RNA drugs by Kristin Jensen $BIIB $IONS https://www.biopharmadive.com/news/biogen-alcyone-acquire-drug-delivery-brain-antisense-oligonucleotides/760504/ https://www.biopharmadive.com/news/biogen-alcyone-acquire-drug-delivery-brain-antisense-oligonucleotides/760504/"
X Link 2025-09-18T15:10Z [----] followers, [---] engagements

"Arvinas reboots cuts more staff; Porges joins Lazard $ARVN $PFE $REGN $VRTX https://www.biopharmadive.com/news/arvinas-pfizer-out-license-porges-lazard-vertex-casgevy-italy/760567/ https://www.biopharmadive.com/news/arvinas-pfizer-out-license-porges-lazard-vertex-casgevy-italy/760567/"
X Link 2025-09-19T15:23Z [----] followers, [---] engagements

"Pfizer buys back into obesity drug chase with $4.9B Metsera deal @ByJonGardner $MTSR $PFE $LLY $NVO https://www.biopharmadive.com/news/pfizer-metsera-acquire-obesity-drugs-glp1-amylin/760719/ https://www.biopharmadive.com/news/pfizer-metsera-acquire-obesity-drugs-glp1-amylin/760719/"
X Link 2025-09-22T16:04Z [----] followers, [---] engagements

"Capricor readies revised FDA pitch for #Duchenne cell therapy by Kristin Jensen $CAPR + 8% https://www.biopharmadive.com/news/capricor-resubmit-fda-deramiocel-duchenne-cardiomyopathy/761088/ https://www.biopharmadive.com/news/capricor-resubmit-fda-deramiocel-duchenne-cardiomyopathy/761088/"
X Link 2025-09-25T14:52Z [----] followers, [---] engagements

"Lillys oral SERD gets FDA nod in advanced breast cancer $LLY $ARVN $PFE $RHHBY $AZN https://www.biopharmadive.com/news/eli-lilly-fda-approve-inluriyo-breast-cancer-oral-serd/761188/ https://www.biopharmadive.com/news/eli-lilly-fda-approve-inluriyo-breast-cancer-oral-serd/761188/"
X Link 2025-09-25T20:40Z [----] followers, [---] engagements

"Star raises another $125M for its blood disease drug by @gwendolynawu #biotech #startups $RHHBY https://www.biopharmadive.com/news/star-therapeutics-von-willebrand-series-d/761286/ https://www.biopharmadive.com/news/star-therapeutics-von-willebrand-series-d/761286/"
X Link 2025-09-30T11:48Z [----] followers, [---] engagements

"Crystalys debuts with $205M and plans for a better gout drug by @gwendolynawu #biotech #startups $AMGN $ESALF https://www.biopharmadive.com/news/crystalys-gout-drug-dotinurad-startup-launch/761383/ https://www.biopharmadive.com/news/crystalys-gout-drug-dotinurad-startup-launch/761383/"
X Link 2025-09-30T12:35Z [----] followers, [---] engagements

"As shutdown begins FDA to stop accepting new drug submissions by Kristin Jensen https://www.biopharmadive.com/news/fda-government-shutdown-new-drug-applications-reviews/761576/ https://www.biopharmadive.com/news/fda-government-shutdown-new-drug-applications-reviews/761576/"
X Link 2025-10-01T14:19Z [----] followers, [---] engagements

"Amgen claims landmark study result that could widen heart drugs use @ByJonGardner $AMGN $REGN $MRK $AZN https://www.biopharmadive.com/news/amgen-repatha-primary-prevention-vesalius-results-pcsk9/801795/ https://www.biopharmadive.com/news/amgen-repatha-primary-prevention-vesalius-results-pcsk9/801795/"
X Link 2025-10-02T16:03Z [----] followers, [---] engagements

"Peter Marks former top FDA vaccine official joins Eli Lilly @ByJonGardner $LLY https://www.biopharmadive.com/news/peter-marks-eli-lilly-fda-infectious-disease-discovery/802258/ https://www.biopharmadive.com/news/peter-marks-eli-lilly-fda-infectious-disease-discovery/802258/"
X Link 2025-10-07T20:22Z [----] followers, [---] engagements

"Venture firms pour $101M into a #biotech using the brain to fix the immune system by @realJacobBell #startups https://www.biopharmadive.com/news/nilo-launch-biotech-column-brain-immune-lux-gates-zuker/802339/ https://www.biopharmadive.com/news/nilo-launch-biotech-column-brain-immune-lux-gates-zuker/802339/"
X Link 2025-10-08T16:18Z [----] followers, [---] engagements

"A regenerative therapy for hair loss attracts a mega-fundraising round by @realJacobBell #biotech #startups https://www.biopharmadive.com/news/pelage-hair-loss-therapy-drug-fundraise-series-b-arch-gv/802857/ https://www.biopharmadive.com/news/pelage-hair-loss-therapy-drug-fundraise-series-b-arch-gv/802857/"
X Link 2025-10-15T16:11Z [----] followers, [---] engagements

"J&J Cuts Ribbon on Boston Innovation Center Touts Startup Deals http://t.co/mnV1gIbDzt $JNJ http://www.xconomy.com/boston/2013/06/27/jj-cuts-ribbon-on-boston-innovation-center/ http://www.xconomy.com/boston/2013/06/27/jj-cuts-ribbon-on-boston-innovation-center/"
X Link 2013-06-27T11:31Z [----] followers, [--] engagements

"Alnylams Amyloidosis Drug Holds up in Second Clinical Trial http://t.co/TLJdtkwLbr $ALNY http://www.xconomy.com/boston/2013/07/01/alnylams-amyloidosis-drug-holds-up-in-second-clinical-trial/ http://www.xconomy.com/boston/2013/07/01/alnylams-amyloidosis-drug-holds-up-in-second-clinical-trial/"
X Link 2013-07-01T13:35Z [----] followers, [--] engagements

"East Coast Life Sciences Roundup: Verdine Vedanta Alnylam & More http://t.co/QJl5aXOcgI $SNY $JNJ $ALNY $INSM $NVS $EPZM $ACHN $CELG http://www.xconomy.com/boston/2013/07/05/east-coast-life-sciences-roundup-verdine-vedanta-alnylam-more/ http://www.xconomy.com/boston/2013/07/05/east-coast-life-sciences-roundup-verdine-vedanta-alnylam-more/"
X Link 2013-07-05T11:36Z [----] followers, [--] engagements

"New Enterprise Associates Sets up Shop in Kendall Square http://t.co/wkumrBKm9H @NEAVC http://www.xconomy.com/boston/2013/11/14/new-enterprise-associates-sets-shop-kendall-square/ http://www.xconomy.com/boston/2013/11/14/new-enterprise-associates-sets-shop-kendall-square/"
X Link 2013-11-14T12:37Z [----] followers, [--] engagements

"East Coast Biotech Roundup: Gerngross Akili Intercept & More http://t.co/6QyvbXJ8wf $PFE $ICPT $BIIB $SGMO $MDT $EPZM $ARNI $IRWD http://www.xconomy.com/boston/2014/01/10/east-coast-biotech-roundup-gerngross-akili-intercept-more/ http://www.xconomy.com/boston/2014/01/10/east-coast-biotech-roundup-gerngross-akili-intercept-more/"
X Link 2014-01-10T12:39Z [----] followers, [--] engagements

"Alnylam Wheels Deals and Gets $700M Investment From Genzyme http://t.co/3ibpot3Wxd $ALNY http://www.xconomy.com/boston/2014/01/13/alnylam-wheels-deals-and-gets-700m-investment-from-genzyme/ http://www.xconomy.com/boston/2014/01/13/alnylam-wheels-deals-and-gets-700m-investment-from-genzyme/"
X Link 2014-01-13T07:10Z [----] followers, [--] engagements

"East Coast Biotech Roundup: Genocea Eleven NIH/Pharma & More http://t.co/e6SQkqwhHN $GNCA $EBIO $PFE $BMY $BIIB $MRK $AMGN $INCY $AGIO http://www.xconomy.com/boston/2014/02/07/east-coast-biotech-roundup-genocea-eleven-nihpharma-more/ http://www.xconomy.com/boston/2014/02/07/east-coast-biotech-roundup-genocea-eleven-nihpharma-more/"
X Link 2014-02-07T13:13Z [----] followers, [--] engagements

"East Coast Biotech Roundup: Neurophage Boston Biotech Insmed & More http://t.co/A90wNW4vIw $GILD $INSM $BIIB $SNDX $ALNY $RTRX $BLUE http://www.xconomy.com/boston/2014/03/28/east-coast-biotech-roundup-neurophage-boston-biotech-insmed-more/ http://www.xconomy.com/boston/2014/03/28/east-coast-biotech-roundup-neurophage-boston-biotech-insmed-more/"
X Link 2014-03-28T12:03Z [----] followers, [--] engagements

"East Coast Biotech Roundup: Sarepta Alkermes Boston Biotech & More http://t.co/1LIAxjADm3 $SRPT $ALKS $ALNY $CBST $ZFGN $CELG $ENTA http://www.xconomy.com/boston/2014/04/25/east-coast-biotech-roundup-sarepta-alkermes-boston-biotech-more/ http://www.xconomy.com/boston/2014/04/25/east-coast-biotech-roundup-sarepta-alkermes-boston-biotech-more/"
X Link 2014-04-25T11:35Z [----] followers, [--] engagements

"John Maraganore: From "Prototypical Geek" To Canny @Alnylam Chief http://t.co/ZqSpgB4xgc #biotech $ALNY http://www.xconomy.com/boston/2014/09/07/john-maraganore-from-prototypical-geek-to-canny-alnylam-chief/ http://www.xconomy.com/boston/2014/09/07/john-maraganore-from-prototypical-geek-to-canny-alnylam-chief/"
X Link 2014-09-08T11:32Z [----] followers, [--] engagements

"East Coast Biotech Roundup: Agios Vertex Epizyme Celldex & More http://t.co/R2ATNizkd9 $AGIO $CLDX $EPZM $FOLD $BIND $DRNA $REGN http://www.xconomy.com/boston/2014/11/21/east-coast-biotech-roundup-agios-vertex-epizyme-celldex-more/ http://www.xconomy.com/boston/2014/11/21/east-coast-biotech-roundup-agios-vertex-epizyme-celldex-more/"
X Link 2014-11-21T14:25Z [----] followers, [--] engagements

"East Coast Biotech Roundup: Yumanity Padlock CAR-T Fever & More http://t.co/5QlaNKQCOc $JUNO $BLCM $VRTX $CELG $BLUE $TTPH $CBST $NPSP http://www.xconomy.com/boston/2014/12/19/east-coast-biotech-roundup-yumanity-padlock-car-t-fever-more/ http://www.xconomy.com/boston/2014/12/19/east-coast-biotech-roundup-yumanity-padlock-car-t-fever-more/"
X Link 2014-12-19T14:29Z [----] followers, [--] engagements

"Yes to Flexus: The Science And Strategy Behind A Huge #biotech Return http://t.co/py8IV9PdnY by @alexlash $BMY $INCY $NLNK $AMGN http://www.xconomy.com/san-francisco/2015/02/26/yes-to-flexus-the-science-and-strategy-behind-a-huge-biotech-return/ http://www.xconomy.com/san-francisco/2015/02/26/yes-to-flexus-the-science-and-strategy-behind-a-huge-biotech-return/"
X Link 2015-02-26T12:01Z [----] followers, [--] engagements

"West Coast #Biotech Roundup: Apple 23andMe Amgen Acadia & More http://t.co/tKMUYYY0rF by @alexlash $AAPL $AMGN $ACAD $GOOG $KYTH $ZGNX http://www.xconomy.com/san-francisco/2015/03/13/west-coast-biotech-roundup-apple-23andme-amgen-acadia-more/ http://www.xconomy.com/san-francisco/2015/03/13/west-coast-biotech-roundup-apple-23andme-amgen-acadia-more/"
X Link 2015-03-13T14:39Z [----] followers, [--] engagements

"Seven Takeaways From Whats Hot in Boston #Biotech http://t.co/Giit6lFcW4 #xconbio $BIIB $VRTX http://www.xconomy.com/boston/2015/04/10/seven-takeaways-from-whats-hot-in-boston-biotech/ http://www.xconomy.com/boston/2015/04/10/seven-takeaways-from-whats-hot-in-boston-biotech/"
X Link 2015-04-10T11:02Z [----] followers, [--] engagements

"Ex-Pfizer Exec Gutierrez-Ramos to Lead Synlogics Smart Bug Plan http://t.co/JBhKlmENQM $PFE @atlasventure #startups http://www.xconomy.com/boston/2015/05/21/ex-pfizer-exec-gutierrez-ramos-to-lead-synlogics-smart-bug-plan/ http://www.xconomy.com/boston/2015/05/21/ex-pfizer-exec-gutierrez-ramos-to-lead-synlogics-smart-bug-plan/"
X Link 2015-05-21T12:00Z [----] followers, [--] engagements

"East Coast #Biotech Roundup: XTuit Spero Unum RNAi Feud & More http://t.co/YTdD6wpPfn $REGN $AGIO $SAGE $ALNY $DRNA $BLUE $CELG $FOLD http://www.xconomy.com/boston/2015/06/12/east-coast-biotech-roundup-xtuit-spero-unum-rnai-feud-more/ http://www.xconomy.com/boston/2015/06/12/east-coast-biotech-roundup-xtuit-spero-unum-rnai-feud-more/"
X Link 2015-06-12T14:07Z [----] followers, [--] engagements

"West Coast Biotech Roundup: Avalanche CytomX BioMarin Dubs & More http://t.co/kIBwcaNm08 by @alexlash $AAVL $AMGN $BMRN $TKMR $KYTH $JUNO http://www.xconomy.com/san-francisco/2015/06/19/west-coast-biotech-roundup-avalanche-cytomx-biomarin-dubs-more/ http://www.xconomy.com/san-francisco/2015/06/19/west-coast-biotech-roundup-avalanche-cytomx-biomarin-dubs-more/"
X Link 2015-06-19T20:40Z [----] followers, [--] engagements

"Keeping Score Clinical Watchdogs Push Drugmakers For More Open Data new column from @alexlash $GSK $GILD $PFE http://www.xconomy.com/national/2015/11/17/keeping-score-clinical-watchdogs-push-drugmakers-for-more-open-data/ http://www.xconomy.com/national/2015/11/17/keeping-score-clinical-watchdogs-push-drugmakers-for-more-open-data/"
X Link 2015-11-17T11:38Z [----] followers, [--] engagements

"ICYMI earlier: Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again w/ Kallyope @Lux_capital http://www.xconomy.com/new-york/2015/12/10/tom-maniatis-gives-ny-biotech-another-jolt-as-kallyope-gets-44m/ http://www.xconomy.com/new-york/2015/12/10/tom-maniatis-gives-ny-biotech-another-jolt-as-kallyope-gets-44m/"
X Link 2015-12-10T21:36Z [----] followers, [--] engagements

"CRISPR Hits Wall Street as Editas Bags $94M in IPO $EDIT $ALNY $ONCE #CRISPR @EditasMed http://www.xconomy.com/boston/2016/02/02/crispr-hits-wall-street-as-editas-bags-94m-in-ipo/ http://www.xconomy.com/boston/2016/02/02/crispr-hits-wall-street-as-editas-bags-94m-in-ipo/"
X Link 2016-02-03T00:18Z [----] followers, [--] engagements

"With BioMarin Data Gene Therapy Finally Shows Impact on #Hemophilia A $BMRN $DMTX $QURE $ONCE http://www.xconomy.com/san-francisco/2016/04/20/with-biomarin-data-gene-therapy-finally-shows-impact-on-hemophilia-a/ http://www.xconomy.com/san-francisco/2016/04/20/with-biomarin-data-gene-therapy-finally-shows-impact-on-hemophilia-a/"
X Link 2016-04-21T00:02Z [----] followers, [--] engagements

"Led by Ex-Suros Execs Nico is Out To Change Brain Surgery #startups $HOLX $BSX http://www.xconomy.com/indiana/2016/04/27/led-by-ex-suros-execs-nico-is-out-to-change-brain-surgery/ http://www.xconomy.com/indiana/2016/04/27/led-by-ex-suros-execs-nico-is-out-to-change-brain-surgery/"
X Link 2016-04-27T10:59Z [----] followers, [--] engagements

"Ariad Sells Off Europe Hub Drug Rights in $140M Incyte Deal $ARIA $INCY http://www.xconomy.com/boston/2016/05/09/ariad-sells-off-europe-hub-drug-rights-in-140m-incyte-deal/ http://www.xconomy.com/boston/2016/05/09/ariad-sells-off-europe-hub-drug-rights-in-140m-incyte-deal/"
X Link 2016-05-09T12:07Z [----] followers, [--] engagements

"Pfizer Moving on From Allergan Pays $5.2B For Anacor Pharma $PFE $ANAC $CELG http://www.xconomy.com/san-francisco/2016/05/16/pfizer-moving-on-from-allergan-pays-5-2b-for-anacor-pharma/ http://www.xconomy.com/san-francisco/2016/05/16/pfizer-moving-on-from-allergan-pays-5-2b-for-anacor-pharma/"
X Link 2016-05-16T12:32Z [----] followers, [--] engagements

"Spero Rolls up More Antibiotics With Vertex Deal $VRTX #startups http://www.xconomy.com/boston/2016/05/25/spero-rolls-up-more-antibiotics-with-vertex-deal/ http://www.xconomy.com/boston/2016/05/25/spero-rolls-up-more-antibiotics-with-vertex-deal/"
X Link 2016-05-25T13:24Z [----] followers, [--] engagements

"Harvards Springer Gets $51.5M From Pharmas Others For Latest Startup $PFE $ABBV $GSK http://www.xconomy.com/boston/2016/06/30/harvards-springer-gets-51-5m-from-pharmas-others-for-latest-startup/ http://www.xconomy.com/boston/2016/06/30/harvards-springer-gets-51-5m-from-pharmas-others-for-latest-startup/"
X Link 2016-06-30T11:30Z [----] followers, [--] engagements

"With $40M Bid Pfizer Set to Buy And Close Bankrupt Bind Tx $BIND $PFE http://www.xconomy.com/boston/2016/07/27/with-40m-bid-pfizer-set-to-buy-and-close-bankrupt-bind-tx/ http://www.xconomy.com/boston/2016/07/27/with-40m-bid-pfizer-set-to-buy-and-close-bankrupt-bind-tx/"
X Link 2016-07-27T14:59Z [----] followers, [--] engagements

"At Big #Hemophilia Meeting More Data and Promise For Gene Therapy $BMRN $ONCE $QURE $SHPG $SGMO http://www.xconomy.com/national/2016/07/28/at-big-hemophilia-meeting-more-data-and-promise-for-gene-therapy/ http://www.xconomy.com/national/2016/07/28/at-big-hemophilia-meeting-more-data-and-promise-for-gene-therapy/"
X Link 2016-07-28T17:01Z [----] followers, [--] engagements

"Seeking to Join Editas Intellia #CRISPR Tx Makes Long Awaited #IPO Push $EDIT $NTLA $VRTX http://www.xconomy.com/boston/2016/09/12/seeking-to-join-editas-intellia-crispr-tx-makes-long-awaited-ipo-push/ http://www.xconomy.com/boston/2016/09/12/seeking-to-join-editas-intellia-crispr-tx-makes-long-awaited-ipo-push/"
X Link 2016-09-12T12:32Z [----] followers, [--] engagements

"After New Data FDA Bucks Advisory Panel Approves #Duchenne Drug $SRPT $BMRN $PTCT http://www.xconomy.com/boston/2016/09/19/after-new-data-fda-bucks-advisory-panel-approves-duchenne-drug/ http://www.xconomy.com/boston/2016/09/19/after-new-data-fda-bucks-advisory-panel-approves-duchenne-drug/"
X Link 2016-09-19T15:00Z [----] followers, [--] engagements

"#Biotech Roundup: Theranos Cuts Alnylam Stops Nobel Eats Its Own & More by @alexlash $ALNY $SRPT $REGN $LLY http://www.xconomy.com/national/2016/10/07/bio-roundup-theranos-cuts-alnylam-stops-nobel-eats-its-own-more/ http://www.xconomy.com/national/2016/10/07/bio-roundup-theranos-cuts-alnylam-stops-nobel-eats-its-own-more/"
X Link 2016-10-07T10:56Z [----] followers, [--] engagements

"After Hubris and Its HCV Collapse Can Vertex Avoid Same Mistakes $VRTX $GILD http://www.xconomy.com/boston/2016/10/18/after-hubris-and-its-hcv-collapse-can-vertex-avoid-same-mistakes/ http://www.xconomy.com/boston/2016/10/18/after-hubris-and-its-hcv-collapse-can-vertex-avoid-same-mistakes/"
X Link 2016-10-18T10:56Z [----] followers, [--] engagements

"#Biotech Roundup: Trumps Rx Silence PCSK9 News Amgens Migraines & More $REGN $AMGN $GILD $MDCO http://www.xconomy.com/national/2016/11/18/bio-roundup-trumps-rx-silence-pcsk9-news-amgens-migraines-more/ http://www.xconomy.com/national/2016/11/18/bio-roundup-trumps-rx-silence-pcsk9-news-amgens-migraines-more/"
X Link 2016-11-18T11:55Z [----] followers, [--] engagements

"14 For 17: Key Clinical Data to Watch For Next Year (Part 1) $REGN $BLUE $AZN $VRTX $AXON http://www.xconomy.com/national/2016/12/21/14-for-17-key-clinical-data-to-watch-for-next-year-part-1/ http://www.xconomy.com/national/2016/12/21/14-for-17-key-clinical-data-to-watch-for-next-year-part-1/"
X Link 2016-12-21T19:19Z [----] followers, [--] engagements

"14 for 17: Key Clinical Data To Watch For Next Year (Part 2) $CLLS $ALNY $SAGE $CELG $ALDR http://www.xconomy.com/national/2016/12/22/14-for-17-key-clinical-data-to-watch-for-next-year-part-2/ http://www.xconomy.com/national/2016/12/22/14-for-17-key-clinical-data-to-watch-for-next-year-part-2/"
X Link 2016-12-22T12:07Z [----] followers, [--] engagements

"Biotech Roundup: JPM Deals Gender Diversity PCSK9 Battle & More #JPM17 $REGN $SRPT $ARIA $VRTX http://www.xconomy.com/national/2017/01/13/biotech-roundup-jpm-deals-gender-diversity-pcsk9-battle-more/ http://www.xconomy.com/national/2017/01/13/biotech-roundup-jpm-deals-gender-diversity-pcsk9-battle-more/"
X Link 2017-01-13T14:08Z [----] followers, [--] engagements

"Investors Sour on Data Debut For Dimensions Hemophilia Gene Therapy $DMTX $ONCE $QURE $BMRN http://www.xconomy.com/boston/2017/01/31/investors-sour-on-data-debut-for-dimensions-hemophilia-gene-therapy/ http://www.xconomy.com/boston/2017/01/31/investors-sour-on-data-debut-for-dimensions-hemophilia-gene-therapy/"
X Link 2017-01-31T17:20Z [----] followers, [--] engagements

"At Arrakis Gilman Teams With Biogen Vets to Target RNA With Pills #startups $BIIB $CELG $PFE http://www.xconomy.com/boston/2017/02/27/at-arrakis-gilman-teams-with-biogen-vets-to-target-rna-with-pills/ http://www.xconomy.com/boston/2017/02/27/at-arrakis-gilman-teams-with-biogen-vets-to-target-rna-with-pills/"
X Link 2017-02-27T12:00Z [----] followers, [--] engagements

"#Biotech Roundup: Spinraza Woes Science March Baseline Launch & More $BIIB $TSRO $NVS $RARE http://www.xconomy.com/national/2017/04/21/bio-roundup-spinraza-woes-science-march-baseline-launch-more/ http://www.xconomy.com/national/2017/04/21/bio-roundup-spinraza-woes-science-march-baseline-launch-more/"
X Link 2017-04-21T11:25Z [----] followers, [--] engagements

"#Biotech Roundup: Big Apple Mo Checkpoint Yes and No CAR-T Death & More by @alexlash $KITE $MRK $PTCT $PFE http://www.xconomy.com/national/2017/05/12/bio-roundup-big-apple-mo-checkpoint-yes-and-no-car-t-death-more/ http://www.xconomy.com/national/2017/05/12/bio-roundup-big-apple-mo-checkpoint-yes-and-no-car-t-death-more/"
X Link 2017-05-12T11:03Z [----] followers, [--] engagements

"Radius Shares Jump as Amgens Bone Drug Suffers a Setback in Phase [--] $AMGN $RDUS $LLY http://www.xconomy.com/san-francisco/2017/05/22/radius-shares-jump-as-amgens-bone-drug-suffers-a-setback-in-phase-3/ http://www.xconomy.com/san-francisco/2017/05/22/radius-shares-jump-as-amgens-bone-drug-suffers-a-setback-in-phase-3/"
X Link 2017-05-22T11:55Z [----] followers, [--] engagements

"Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests $LOXO $RXDX $FMI $TMO #ASCO17 http://www.xconomy.com/national/2017/06/03/precision-steps-can-loxo-drug-help-broaden-use-of-cancer-dna-tests/ http://www.xconomy.com/national/2017/06/03/precision-steps-can-loxo-drug-help-broaden-use-of-cancer-dna-tests/"
X Link 2017-06-03T11:30Z [----] followers, [--] engagements

"#Biotech Roundup: Frazier v. Trump Data Dumps New York Steps & More $MRK $BMY $AZN $REGN $NVO http://www.xconomy.com/national/2017/08/18/bio-roundup-frazier-v-trump-data-dumps-new-york-steps-more/ http://www.xconomy.com/national/2017/08/18/bio-roundup-frazier-v-trump-data-dumps-new-york-steps-more/"
X Link 2017-08-18T12:09Z [----] followers, [--] engagements

"Alnylam Data Puts A Nobel Discovery One Step Closer To Approved Drug $ALNY $IONS $SNY #RNAi http://www.xconomy.com/boston/2017/09/20/alnylam-data-puts-a-nobel-discovery-one-step-closer-to-approved-drug/ http://www.xconomy.com/boston/2017/09/20/alnylam-data-puts-a-nobel-discovery-one-step-closer-to-approved-drug/"
X Link 2017-09-20T11:23Z [----] followers, [--] engagements

"#Biotech Roundup: RNAis Big Day CAR-T For Kids Drugs From Fungi & More $ALNY $NVS $ESRX $ICPT http://www.xconomy.com/national/2017/09/22/bio-roundup-rnais-big-day-car-t-for-kids-drugs-from-fungi-more/ http://www.xconomy.com/national/2017/09/22/bio-roundup-rnais-big-day-car-t-for-kids-drugs-from-fungi-more/"
X Link 2017-09-22T10:58Z [----] followers, [--] engagements

"#Biotech Roundup: Opioid News #ASH17 Preview Boston Bio IPOs & More $JUNO $NVS $BLUE $AVXS $ALNY http://www.xconomy.com/national/2017/11/03/biotech-roundup-opioid-news-ash-preview-boston-bio-ipos-more/ http://www.xconomy.com/national/2017/11/03/biotech-roundup-opioid-news-ash-preview-boston-bio-ipos-more/"
X Link 2017-11-03T11:06Z [----] followers, [--] engagements

"15 For 18: Key Clinical Data to Watch For Next Year (Part 1) $BMY $AVXS $FGEN $XLRN $ESPR https://www.xconomy.com/national/2017/12/04/15-for-18-key-clinical-data-to-watch-for-next-year-part-1/ https://www.xconomy.com/national/2017/12/04/15-for-18-key-clinical-data-to-watch-for-next-year-part-1/"
X Link 2017-12-04T12:01Z [----] followers, [--] engagements

"Gene Therapy Advances But #Hemophilia is no Easy Target $BMRN $ONCE $QURE #GeneTherapy https://www.xconomy.com/national/2017/12/13/gene-therapy-advances-but-hemophilia-is-no-easy-target/ https://www.xconomy.com/national/2017/12/13/gene-therapy-advances-but-hemophilia-is-no-easy-target/"
X Link 2017-12-13T12:05Z [----] followers, [--] engagements

"Notes From the #JPM18 Vortex: Gene Therapys Reckoning and Lonely Cabs $ONCE $BLUE $ALNY https://www.xconomy.com/national/2018/01/11/notes-from-the-jpm-18-vortex-gene-therapys-reckoning-and-lonely-cabs/ https://www.xconomy.com/national/2018/01/11/notes-from-the-jpm-18-vortex-gene-therapys-reckoning-and-lonely-cabs/"
X Link 2018-01-11T13:29Z [----] followers, [--] engagements

"#Biotech Roundup: Lung Cancer Questions Migraine Races HIV Battle & More $BMY $TEVA $GILD $JNJ https://www.xconomy.com/national/2018/02/09/bio-roundup-lung-cancer-questions-migraine-races-hiv-battle-more/ https://www.xconomy.com/national/2018/02/09/bio-roundup-lung-cancer-questions-migraine-races-hiv-battle-more/"
X Link 2018-02-09T12:03Z [----] followers, [--] engagements

"ICYMI: Execs Talk Hurdles As Immunotherapy Combos CAR-T Launches Progress #BIOCEO18 $BMY $MRK $GILD $NVS $MBIO https://www.xconomy.com/new-york/2018/02/12/execs-talk-hurdles-as-immunotherapy-combos-car-t-launches-progress/ https://www.xconomy.com/new-york/2018/02/12/execs-talk-hurdles-as-immunotherapy-combos-car-t-launches-progress/"
X Link 2018-02-13T12:02Z [----] followers, [--] engagements

"With $69M Deal AbbVie Turns to Voyager for an #Alzheimers Gene Therapy $VYGR $ABBV https://www.xconomy.com/boston/2018/02/20/with-69m-deal-abbvie-turns-to-voyager-for-an-alzheimers-gene-therapy/ https://www.xconomy.com/boston/2018/02/20/with-69m-deal-abbvie-turns-to-voyager-for-an-alzheimers-gene-therapy/"
X Link 2018-02-20T13:36Z [----] followers, [--] engagements

"#Biotech Roundup: DIY Biohacking PCSK9 Data Solid Setback & More $REGN $SLDB $IONS $BIIB $GILD https://www.xconomy.com/national/2018/03/16/bio-roundup-diy-biohacking-pcsk9-data-solid-bio-stopped-more/ https://www.xconomy.com/national/2018/03/16/bio-roundup-diy-biohacking-pcsk9-data-solid-bio-stopped-more/"
X Link 2018-03-16T11:01Z [----] followers, [--] engagements

"AbbVie Shares Plummet as $5.8B Bet on Stemcentrx Takes a Hit $ABBV https://www.xconomy.com/national/2018/03/22/abbvie-shares-plummet-as-5-8b-bet-on-stemcentrx-takes-a-hit/ https://www.xconomy.com/national/2018/03/22/abbvie-shares-plummet-as-5-8b-bet-on-stemcentrx-takes-a-hit/"
X Link 2018-03-22T14:48Z [----] followers, [--] engagements

"Racing Allergan Biohaven Touts #Migraine Drug Data But Shares Sink $BHVN $AGN $BMY $MRK $LLY https://www.xconomy.com/new-york/2018/03/26/racing-allergan-biohaven-touts-migraine-drug-data-but-shares-sink/ https://www.xconomy.com/new-york/2018/03/26/racing-allergan-biohaven-touts-migraine-drug-data-but-shares-sink/"
X Link 2018-03-26T12:16Z [----] followers, [--] engagements

"Roche-Exelixis Study Fails as Mixed Year Continues For Cancer Drug Combos $EXEL $ARRY $MRK https://www.xconomy.com/san-francisco/2018/05/10/roche-exelixis-study-fails-as-mixed-year-continues-for-cancer-drug-combos/ https://www.xconomy.com/san-francisco/2018/05/10/roche-exelixis-study-fails-as-mixed-year-continues-for-cancer-drug-combos/"
X Link 2018-05-10T12:32Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing